- Home
- LZ vs VCEL Comparison
LZ vs VCEL Comparison
Compare LZ & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZ
- VCEL
- Stock Information
- Founded
- LZ 2001
- VCEL 1989
- Country
- LZ United States
- VCEL United States
- Employees
- LZ N/A
- VCEL N/A
- Industry
- LZ EDP Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LZ Technology
- VCEL Health Care
- Exchange
- LZ Nasdaq
- VCEL Nasdaq
- Market Cap
- LZ 1.8B
- VCEL 1.8B
- IPO Year
- LZ 2021
- VCEL 1997
- Fundamental
- Price
- LZ $9.56
- VCEL $38.83
- Analyst Decision
- LZ Hold
- VCEL Strong Buy
- Analyst Count
- LZ 8
- VCEL 6
- Target Price
- LZ $11.33
- VCEL $60.40
- AVG Volume (30 Days)
- LZ 2.2M
- VCEL 620.8K
- Earning Date
- LZ 11-05-2025
- VCEL 11-06-2025
- Dividend Yield
- LZ N/A
- VCEL N/A
- EPS Growth
- LZ N/A
- VCEL 236.54
- EPS
- LZ 0.12
- VCEL 0.25
- Revenue
- LZ $727,483,000.00
- VCEL $258,716,999.00
- Revenue This Year
- LZ $11.09
- VCEL $18.35
- Revenue Next Year
- LZ $7.30
- VCEL $22.26
- P/E Ratio
- LZ $78.77
- VCEL $158.26
- Revenue Growth
- LZ 7.17
- VCEL 14.05
- 52 Week Low
- LZ $6.47
- VCEL $29.24
- 52 Week High
- LZ $12.40
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- LZ 39.37
- VCEL 57.82
- Support Level
- LZ $9.75
- VCEL $39.24
- Resistance Level
- LZ $10.33
- VCEL $41.66
- Average True Range (ATR)
- LZ 0.47
- VCEL 1.82
- MACD
- LZ -0.06
- VCEL 0.08
- Stochastic Oscillator
- LZ 1.02
- VCEL 54.64
About LZ LegalZoom.com Inc.
LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.